| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | deaminase binding | 2.74e-06 | 4 | 14 | 2 | GO:1990827 | |
| GeneOntologyMolecularFunction | N6-methyladenosine-containing RNA reader activity | 4.77e-05 | 15 | 14 | 2 | GO:1990247 | |
| GeneOntologyMolecularFunction | protein-RNA adaptor activity | 1.25e-04 | 24 | 14 | 2 | GO:0140517 | |
| GeneOntologyMolecularFunction | telomerase RNA binding | 1.36e-04 | 25 | 14 | 2 | GO:0070034 | |
| GeneOntologyMolecularFunction | poly(U) RNA binding | 2.53e-04 | 34 | 14 | 2 | GO:0008266 | |
| GeneOntologyMolecularFunction | poly-pyrimidine tract binding | 3.33e-04 | 39 | 14 | 2 | GO:0008187 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.07e-03 | 70 | 14 | 2 | GO:0003777 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | 2.09e-03 | 1418 | 14 | 5 | GO:0030234 | |
| GeneOntologyMolecularFunction | single-stranded RNA binding | 2.67e-03 | 111 | 14 | 2 | GO:0003727 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 3.01e-03 | 118 | 14 | 2 | GO:0003774 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 4.81e-03 | 507 | 14 | 3 | GO:0030695 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 4.81e-03 | 507 | 14 | 3 | GO:0060589 | |
| GeneOntologyMolecularFunction | ribonucleoprotein complex binding | 8.88e-03 | 206 | 14 | 2 | GO:0043021 | |
| GeneOntologyMolecularFunction | mRNA 3'-UTR binding | 1.55e-02 | 276 | 14 | 2 | GO:0003730 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 1.58e-02 | 279 | 14 | 2 | GO:0005096 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA modification | 6.41e-06 | 6 | 14 | 2 | GO:0090367 | |
| GeneOntologyBiologicalProcess | regulation of mRNA modification | 8.97e-06 | 7 | 14 | 2 | GO:0090365 | |
| GeneOntologyBiologicalProcess | negative regulation of telomere maintenance via telomerase | 1.27e-04 | 25 | 14 | 2 | GO:0032211 | |
| GeneOntologyBiologicalProcess | mRNA modification | 1.38e-04 | 26 | 14 | 2 | GO:0016556 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | 1.43e-04 | 1342 | 14 | 6 | GO:0033043 | |
| GeneOntologyBiologicalProcess | 3'-UTR-mediated mRNA stabilization | 1.97e-04 | 31 | 14 | 2 | GO:0070935 | |
| GeneOntologyBiologicalProcess | negative regulation of telomere maintenance via telomere lengthening | 2.23e-04 | 33 | 14 | 2 | GO:1904357 | |
| GeneOntologyBiologicalProcess | negative regulation of telomere maintenance | 3.63e-04 | 42 | 14 | 2 | GO:0032205 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA biosynthetic process | 3.80e-04 | 43 | 14 | 2 | GO:2000279 | |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance via telomerase | 7.40e-04 | 60 | 14 | 2 | GO:0032210 | |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance via telomere lengthening | 9.78e-04 | 69 | 14 | 2 | GO:1904356 | |
| GeneOntologyBiologicalProcess | mRNA stabilization | 1.22e-03 | 77 | 14 | 2 | GO:0048255 | |
| GeneOntologyBiologicalProcess | telomere maintenance via telomerase | 1.22e-03 | 77 | 14 | 2 | GO:0007004 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 1.41e-03 | 83 | 14 | 2 | GO:0006278 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA catabolic process | 1.55e-03 | 87 | 14 | 2 | GO:1902373 | |
| GeneOntologyBiologicalProcess | RNA stabilization | 1.58e-03 | 88 | 14 | 2 | GO:0043489 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 1.64e-03 | 358 | 14 | 3 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 1.64e-03 | 358 | 14 | 3 | GO:0000377 | |
| GeneOntologyBiologicalProcess | telomere maintenance via telomere lengthening | 1.66e-03 | 90 | 14 | 2 | GO:0010833 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 1.69e-03 | 362 | 14 | 3 | GO:0000375 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA catabolic process | 2.08e-03 | 101 | 14 | 2 | GO:1902369 | |
| GeneOntologyBiologicalProcess | negative regulation of chromosome organization | 2.33e-03 | 107 | 14 | 2 | GO:2001251 | |
| GeneOntologyBiologicalProcess | regulation of cilium assembly | 2.37e-03 | 108 | 14 | 2 | GO:1902017 | |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance | 2.55e-03 | 112 | 14 | 2 | GO:0032204 | |
| GeneOntologyBiologicalProcess | negative regulation of organelle organization | 2.60e-03 | 421 | 14 | 3 | GO:0010639 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 2.68e-03 | 115 | 14 | 2 | GO:1903312 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 3.00e-03 | 443 | 14 | 3 | GO:1903311 | |
| GeneOntologyBiologicalProcess | cilium assembly | 3.02e-03 | 444 | 14 | 3 | GO:0060271 | |
| GeneOntologyBiologicalProcess | cilium organization | 3.68e-03 | 476 | 14 | 3 | GO:0044782 | |
| GeneOntologyBiologicalProcess | regulation of DNA biosynthetic process | 3.84e-03 | 138 | 14 | 2 | GO:2000278 | |
| GeneOntologyBiologicalProcess | RNA splicing | 4.27e-03 | 502 | 14 | 3 | GO:0008380 | |
| GeneOntologyCellularComponent | nucleoplasmic periphery of the nuclear pore complex | 6.24e-06 | 6 | 14 | 2 | GO:1990826 | |
| GeneOntologyCellularComponent | telomerase holoenzyme complex | 1.24e-04 | 25 | 14 | 2 | GO:0005697 | |
| GeneOntologyCellularComponent | pronucleus | 1.56e-04 | 28 | 14 | 2 | GO:0045120 | |
| GeneOntologyCellularComponent | dynein complex | 5.84e-04 | 54 | 14 | 2 | GO:0030286 | |
| GeneOntologyCellularComponent | catalytic step 2 spliceosome | 1.87e-03 | 97 | 14 | 2 | GO:0071013 | |
| GeneOntologyCellularComponent | microtubule associated complex | 5.05e-03 | 161 | 14 | 2 | GO:0005875 | |
| GeneOntologyCellularComponent | actin cytoskeleton | 6.04e-03 | 576 | 14 | 3 | GO:0015629 | |
| GeneOntologyCellularComponent | spliceosomal complex | 8.83e-03 | 215 | 14 | 2 | GO:0005681 | |
| Domain | hnRNP_C | 7.81e-06 | 6 | 14 | 2 | IPR017347 | |
| Domain | RRM_1 | 4.53e-04 | 208 | 14 | 3 | PF00076 | |
| Domain | RRM | 5.12e-04 | 217 | 14 | 3 | SM00360 | |
| Domain | RRM_dom | 5.84e-04 | 227 | 14 | 3 | IPR000504 | |
| Domain | RRM | 6.07e-04 | 230 | 14 | 3 | PS50102 | |
| Domain | - | 7.21e-04 | 244 | 14 | 3 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 8.47e-04 | 258 | 14 | 3 | IPR012677 | |
| Domain | PH | 1.05e-03 | 278 | 14 | 3 | SM00233 | |
| Domain | PH_DOMAIN | 1.06e-03 | 279 | 14 | 3 | PS50003 | |
| Domain | PH_domain | 1.07e-03 | 280 | 14 | 3 | IPR001849 | |
| Domain | - | 2.79e-03 | 391 | 14 | 3 | 2.30.29.30 | |
| Domain | PH_dom-like | 3.56e-03 | 426 | 14 | 3 | IPR011993 | |
| Domain | PH | 1.24e-02 | 229 | 14 | 2 | PF00169 | |
| Pathway | REACTOME_RHOBTB2_GTPASE_CYCLE | 1.07e-06 | 25 | 12 | 3 | MM15606 | |
| Pathway | REACTOME_RHOBTB_GTPASE_CYCLE | 3.60e-06 | 37 | 12 | 3 | MM15683 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 1.89e-05 | 439 | 12 | 5 | MM15595 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | 1.23e-04 | 649 | 12 | 5 | MM15690 | |
| Pathway | REACTOME_RHOBTB1_GTPASE_CYCLE | 1.97e-04 | 25 | 12 | 2 | MM15608 | |
| Pathway | REACTOME_MRNA_SPLICING | 5.71e-04 | 201 | 12 | 3 | MM15411 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 1.07e-03 | 58 | 12 | 2 | MM15149 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 1.45e-03 | 277 | 12 | 3 | MM15414 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 5.73e-03 | 450 | 12 | 3 | M27078 | |
| Pathway | WP_MRNA_PROCESSING | 5.77e-03 | 451 | 12 | 3 | MM15946 | |
| Pubmed | 9.02e-07 | 4 | 14 | 2 | 23831410 | ||
| Pubmed | hnRNP C is required for postimplantation mouse development but Is dispensable for cell viability. | 9.02e-07 | 4 | 14 | 2 | 10805751 | |
| Pubmed | 9.02e-07 | 4 | 14 | 2 | 36681355 | ||
| Pubmed | hnRNPC induces isoform shifts in miR-21-5p leading to cancer development. | 9.02e-07 | 4 | 14 | 2 | 35729324 | |
| Pubmed | 1.50e-06 | 5 | 14 | 2 | 9128719 | ||
| Pubmed | Evaluating the role of hnRNP-C and FMRP in the cAMP-induced APP metabolism. | 1.50e-06 | 5 | 14 | 2 | 25809670 | |
| Pubmed | 1.50e-06 | 5 | 14 | 2 | 29846695 | ||
| Pubmed | 2.25e-06 | 6 | 14 | 2 | 15687492 | ||
| Pubmed | Selective disruption of genes expressed in totipotent embryonal stem cells. | 2.25e-06 | 6 | 14 | 2 | 1317320 | |
| Pubmed | 2.25e-06 | 6 | 14 | 2 | 26048669 | ||
| Pubmed | 2.25e-06 | 6 | 14 | 2 | 18363099 | ||
| Pubmed | 3.16e-06 | 7 | 14 | 2 | 25846207 | ||
| Pubmed | 5.41e-06 | 9 | 14 | 2 | 10452948 | ||
| Pubmed | Interaction between nucleosome assembly protein 1-like family members. | 9.91e-06 | 12 | 14 | 2 | 21333655 | |
| Pubmed | The biogenesis of the coiled body during early mouse development. | 9.91e-06 | 12 | 14 | 2 | 7768196 | |
| Pubmed | A method to identify cDNAs based on localization of green fluorescent protein fusion products. | 2.04e-05 | 17 | 14 | 2 | 10716735 | |
| Pubmed | Stage-specific changes in gene expression in acutely isolated mouse CNS progenitor cells. | 4.86e-05 | 26 | 14 | 2 | 15890332 | |
| Pubmed | Misregulation of Alternative Splicing in a Mouse Model of Rett Syndrome. | 1.75e-04 | 49 | 14 | 2 | 27352031 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 3.77e-04 | 363 | 14 | 3 | 14691545 | |
| Interaction | HNRNPCL3 interactions | 9.64e-05 | 23 | 13 | 2 | int:HNRNPCL3 | |
| Interaction | PLXNA4 interactions | 1.44e-04 | 28 | 13 | 2 | int:PLXNA4 | |
| Interaction | ZCCHC3 interactions | 1.61e-04 | 171 | 13 | 3 | int:ZCCHC3 | |
| Interaction | CRNKL1 interactions | 1.79e-04 | 177 | 13 | 3 | int:CRNKL1 | |
| Cytoband | 1p36.21 | 1.67e-04 | 63 | 14 | 2 | 1p36.21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p15 | 1.24e-02 | 564 | 14 | 2 | chr11p15 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | 1.78e-02 | 681 | 14 | 2 | chr1p36 | |
| GeneFamily | Dyneins, axonemal | 4.55e-05 | 17 | 11 | 2 | 536 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 6.64e-03 | 206 | 11 | 2 | 682 | |
| GeneFamily | RNA binding motif containing | 7.08e-03 | 213 | 11 | 2 | 725 | |
| Coexpression | GSE22033_WT_VS_PPARG_KO_MEF_DN | 1.48e-04 | 199 | 14 | 3 | M7692 | |
| Coexpression | GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_UP | 1.48e-04 | 199 | 14 | 3 | M5692 | |
| Coexpression | GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_UP | 1.50e-04 | 200 | 14 | 3 | M7430 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN | 1.75e-04 | 37 | 14 | 2 | MM570 | |
| ToppCell | droplet-Fat-SCAT-30m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 194 | 14 | 3 | 0e315c63407fa00643722a7d6138b1502f79b10d | |
| ToppCell | droplet-Fat-SCAT-30m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 194 | 14 | 3 | c2990d6eda3954dc01913bf3910df79f06e0010a | |
| ToppCell | droplet-Fat-SCAT-30m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 194 | 14 | 3 | 588c45dafa00547b2506e298a2434b1b5e15560d | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.04e-05 | 200 | 14 | 3 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.04e-05 | 200 | 14 | 3 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.04e-05 | 200 | 14 | 3 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.04e-05 | 200 | 14 | 3 | 3bdba9612cd7c612b76aa9abecc4a6529aabfc1c | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.04e-05 | 200 | 14 | 3 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Sema3e|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.33e-04 | 73 | 14 | 2 | 51bcbb57ee6c45cad88cb3e2cedab2cf3503b2a5 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Sema3e-Excitatory_Neuron.Sc17a7.Sema3e-Nnat_(Layer_6)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.31e-04 | 87 | 14 | 2 | 7518ca56d626619d9706505169a85f1850105608 | |
| ToppCell | Severe-B_intermediate-14|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.78e-04 | 142 | 14 | 2 | f9cbc266fcea19bec504be4f3a28d1173c6b2e3c | |
| ToppCell | COVID-19_Moderate-multiplets|COVID-19_Moderate / disease group, cell group and cell class | 9.40e-04 | 147 | 14 | 2 | baf15c773d7751bc6f64d4974a22738626f2b3ff | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.40e-04 | 147 | 14 | 2 | 55f4b3289094a1eab6d7a6c8f214ec7b031edfa8 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Col18a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.53e-04 | 148 | 14 | 2 | fc80c02b51cf55a04ce550838ee2f41d8f656f41 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.53e-04 | 148 | 14 | 2 | 5e738522d4ad35e08bc4ff8c41b7bea38ec6ef95 | |
| ToppCell | COVID-19_Severe-B_cell|World / disease group, cell group and cell class | 9.66e-04 | 149 | 14 | 2 | 9a9fcbf7e8a6811958f3fd2d36315e19ab2b1127 | |
| ToppCell | Myeloid-Myeloid-E_(Neutrophils)|Myeloid / shred on cell class and cell subclass (v4) | 9.79e-04 | 150 | 14 | 2 | 1bffb8d86b737ac43be902d9468041aef3542f1f | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-9|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.92e-04 | 151 | 14 | 2 | 2314c004434aed9b7fa1ad01c61c43e5ed4a18ce | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_AB-8|TCGA-Thymus / Sample_Type by Project: Shred V9 | 9.92e-04 | 151 | 14 | 2 | 5906562efd36fbcb91f96e0a0d3a8fe999ba1e79 | |
| ToppCell | COVID-19_Moderate-multiplets|World / disease group, cell group and cell class | 1.06e-03 | 156 | 14 | 2 | afdc025fa75e7926b1cc182c4a33654a2186abb1 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-B_cells-Cycling_B_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-03 | 156 | 14 | 2 | 203ef22eb76bd2b829b027c30af0557080f4006c | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.06e-03 | 156 | 14 | 2 | 895927228c93cd090303984c5be6ebfb59ed6f3a | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-pDC_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.07e-03 | 157 | 14 | 2 | 62f029831c420d3e9580822177545eb7fdf4d0a3 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.08e-03 | 158 | 14 | 2 | 7274f020c0ecf216da4b6689c62bc5f49c29b6f3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_SOX11|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-03 | 159 | 14 | 2 | 255094ca07b09c68c00f45f2490fe775b25efbba | |
| ToppCell | 343B-Myeloid-Dendritic-cDC1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.13e-03 | 161 | 14 | 2 | 537a1d86de99a493b0345ca0f760994260e97049 | |
| ToppCell | Influenza_Severe-gd_T|World / Disease group and Cell class | 1.13e-03 | 161 | 14 | 2 | b3cdaed4d58d57e3c5dbc904a09388f3bf949407 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_TNFAIP8L3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.18e-03 | 165 | 14 | 2 | cd73bba51f3f4871533c3512bdc0a1f05716344b | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-NK_CD56bright|ICU-NoSEP / Disease, Lineage and Cell Type | 1.21e-03 | 167 | 14 | 2 | f4f188a8efca8cdd0ecfb857fe4538c10847eadd | |
| ToppCell | Control-Myeloid-MoAM1,_IL1R2|Myeloid / Condition, Lineage and Cell class | 1.21e-03 | 167 | 14 | 2 | 6e5140527437193f441ca96893b9a00d346614f3 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.21e-03 | 167 | 14 | 2 | ded4d6cccd3660662f12cf5a512de31d26325f1b | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.22e-03 | 168 | 14 | 2 | 943687a33fffd7e19d906b9dd385a126bcea109a | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Col23a1_Adamts2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.22e-03 | 168 | 14 | 2 | 3fe432267656aff81b6d92c18d1b6fc0cde73d6a | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-B_cells-LZ_GC_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.22e-03 | 168 | 14 | 2 | 08eb1284f9b8bd3e0e4b21bfc2bbee01d35a0bd7 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-03 | 168 | 14 | 2 | eeb381b62c7ba263af96de1194ed59e57b6ca3ae | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-03 | 168 | 14 | 2 | 063d0368d656962b335154c230bdcd9236e7c9ad | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-03 | 168 | 14 | 2 | a7c4251d8a83bc30196a444028a35c17c24dc291 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_ETV4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.24e-03 | 169 | 14 | 2 | 716e9d4c5fb99c56b76afaa5ed90bfa859fde802 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Granulocytic-Basophil|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-03 | 169 | 14 | 2 | b23d0aaa2da333b9c69a7aee862d5a5d2a1bf79b | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-CD45____B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-03 | 169 | 14 | 2 | d44fc49056799dfc70a3c7d538c210d88ffded05 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-03 | 169 | 14 | 2 | 83d1bcf33872b01ea9614f608a3e4ab30df25c7e | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-03 | 169 | 14 | 2 | c5015ddb838849ea892a2cae5a739b554eb6d793 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_ETV4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.24e-03 | 169 | 14 | 2 | ccb7b2daa65cb5f4c1e7a48b3bcdf0cb8f7675c3 | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-03 | 170 | 14 | 2 | 53fd50c9a27d47662fbcbd7e9e9837f72ac448c5 | |
| ToppCell | Severe-Lymphoid-T-|Severe / Condition, Lineage, Cell class and cell subclass | 1.25e-03 | 170 | 14 | 2 | 5788e1158fde036937d41708e9db3222ca351eb1 | |
| ToppCell | Influenza_Severe-gd_T|Influenza_Severe / Disease group and Cell class | 1.25e-03 | 170 | 14 | 2 | 59009c5a504ea8c6b4f6697299db219fd5edf7d6 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC-DC-DC1|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.27e-03 | 171 | 14 | 2 | 04346d4eb726875e3537e215ea081a0318ca4ddd | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-03 | 171 | 14 | 2 | 20ac3de9c164b409b70a30a8b6544ea491ef7c0e | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Cytotoxic_CD8+_T|normal_Pleural_Fluid / Location, Cell class and cell subclass | 1.27e-03 | 171 | 14 | 2 | 6be81c20f4e962b414afcedfe478dd59c510d1e1 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-Immature_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.28e-03 | 172 | 14 | 2 | 0bcb960c5ab0d3cbbdf6235b6f28327ea60ba3e3 | |
| ToppCell | 3'_v3-blood-Lymphocytic_B-Naive_B_cells|blood / Manually curated celltypes from each tissue | 1.28e-03 | 172 | 14 | 2 | f16f90d17feac1ee52fd513907b28456865fd31d | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-03 | 173 | 14 | 2 | 25d72fa7a84baf5660ead6da67327590f5c91860 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-03 | 173 | 14 | 2 | 886ac1b98f709ad7131df778b83712bf8ed313de | |
| ToppCell | droplet-Marrow-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-03 | 174 | 14 | 2 | a188ec192c378f731af1c95eb8f1392a2bb18c26 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.31e-03 | 174 | 14 | 2 | 26ca6ebaa0081108d44c01f8ca56a63724f1c99d | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.31e-03 | 174 | 14 | 2 | b4c2d1c029fcd0d4926aa79a5b789c713919dcf3 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.31e-03 | 174 | 14 | 2 | 9eb3504f9340517ef5d056503044fbdb9ffeb714 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.31e-03 | 174 | 14 | 2 | 7c8704766dd4c80250754b5ee9907b342b9c2623 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.31e-03 | 174 | 14 | 2 | cc493654ea3517bc6a145c7f787f304929636f86 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-LZ_GC_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-03 | 174 | 14 | 2 | fde40c5d51f5380088360dc5a583eb04e518deb6 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.31e-03 | 174 | 14 | 2 | 9aa2168d3bcef7cdc5a47442618cb8e9eb24c95b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.31e-03 | 174 | 14 | 2 | ebe6ce173ad12d4a2afa39f8d6185c0e4f97fb1e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-03 | 175 | 14 | 2 | 12f5fd83c7710fc0c77406f765d9cbd133433b8b | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-03 | 175 | 14 | 2 | 427a7ee92fe16a90625946492062d37aa0f7235b | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.33e-03 | 175 | 14 | 2 | c227fc5d1ccb69b82a96a6354913cafaf27d0eec | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-03 | 175 | 14 | 2 | 1d8aab491dcc27ea5dbfb6462d18ee280b21a05e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-03 | 175 | 14 | 2 | 1b4cefae400bf756d09ece32d3f5c0bd4c6ad73f | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-03 | 175 | 14 | 2 | 738b3d476ac494e2e79b70b3b83bc1b7ae8396bd | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-03 | 176 | 14 | 2 | 741fdacb33d49b030a797a6099fdea0949a22e75 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Penk_Fst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.34e-03 | 176 | 14 | 2 | a1b9f8f199a028b3fa85de43fe96bc29f387bfd8 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-nan|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-03 | 176 | 14 | 2 | 1dd54bfaa58541de51e5a8328651d390833bd480 | |
| ToppCell | LPS_only-Lymphocytic_B-B_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-03 | 177 | 14 | 2 | c82332c5f656aa26513e4f7525d5d4d733019725 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.36e-03 | 177 | 14 | 2 | 840eaac045ada42cae0ab81177d1d0ae55a65633 | |
| ToppCell | LPS_only-Lymphocytic_B-B_cells-B-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-03 | 177 | 14 | 2 | 8a955a7ab84c434f9ad4b467246b8be3cb479406 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Zbtb32+_B_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.36e-03 | 177 | 14 | 2 | a58c93be9767e3fe8fbb6b0db1210d3a33aac662 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.36e-03 | 177 | 14 | 2 | c506b8fd9a550e6cf93b64a1f7eed2543224a140 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.36e-03 | 177 | 14 | 2 | 3ed383e5c0b15d9d5e75b98cf6d10609f48fc422 | |
| ToppCell | LPS_only-Lymphocytic_B|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-03 | 177 | 14 | 2 | 5ed65e08d773d157840317c72e0d43c261d438d4 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-8|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.36e-03 | 177 | 14 | 2 | 066e7500e7bdde88a7914f50a4661d8adf6db925 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.37e-03 | 178 | 14 | 2 | 5d41fede13c8e64b6fdaf2155f1eb72bcfc32fdb | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.37e-03 | 178 | 14 | 2 | 20d9433332b58270bca6807a6cf633971dbaa2b7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Mesenchymal-Mes-Myofibroblast|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.37e-03 | 178 | 14 | 2 | 1802ff1c6cb18ee62cfef7270c0971048fae5315 | |
| ToppCell | B_cells-Naive_B_cells_|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.37e-03 | 178 | 14 | 2 | 71ac2eca5cf13a91f86b80690748b0788392dcfc | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.37e-03 | 178 | 14 | 2 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic-B_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-03 | 178 | 14 | 2 | 5b6f7e8a930c239db1f31edfb61b2b9228d28663 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Mesenchymal-Mes-Myofibroblast-VLMC_L1-3_CYP1B1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.37e-03 | 178 | 14 | 2 | 4368d20130e5a08716564c19470b6014f16902ac | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.37e-03 | 178 | 14 | 2 | a493a277d175e5e153410a745b26ebe2e0839ea0 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.37e-03 | 178 | 14 | 2 | 371218babddfd3d8a7bb82a46ce65327ee3fcf12 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-03 | 178 | 14 | 2 | 9b932b677ae05ac6e12cd6ce97789f8c10e4790b | |
| ToppCell | -Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 1.39e-03 | 179 | 14 | 2 | e4224b2e9c4ae7da62cf670adf811f4112c7d060 | |
| ToppCell | Leuk-UTI-Lymphocyte-B-B_intermediate|Leuk-UTI / Disease, Lineage and Cell Type | 1.39e-03 | 179 | 14 | 2 | 01933f6fa94d7032ed403a6cae6985cafa820043 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.39e-03 | 179 | 14 | 2 | b559f5a72cc9e3e35d05cb539b5c2e006e56e652 | |
| ToppCell | Mild-Lymphoid-T-innate_T|Mild / Condition, Lineage, Cell class and cell subclass | 1.39e-03 | 179 | 14 | 2 | abc0fbe101a464a2c85755a974a3d5c2b968fe46 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.40e-03 | 180 | 14 | 2 | d8135f73a89b97168f2048258f4648e23536ece4 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-Zbtb32+_B_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.40e-03 | 180 | 14 | 2 | c12c1cc206f7e63e5722471bd3eb84caddb84129 | |
| ToppCell | COVID-19-kidney-Bcells|kidney / Disease (COVID-19 only), tissue and cell type | 1.40e-03 | 180 | 14 | 2 | 5650fc7ebcdf5e0be9a217a58d36a8386d59fd1b | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-03 | 180 | 14 | 2 | e5bbd0e204da4f98254e3484b383ec1c277b4209 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-03 | 180 | 14 | 2 | 32c6a3886428d82fb4355d987c6d2645f333447b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-03 | 180 | 14 | 2 | c2746092ef251e9d5910fe96461afdd0624a24c6 | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-03 | 180 | 14 | 2 | b673d11d764e275883fc5edbad97137a6549df6a | |
| Drug | AC1L2R3A | 4.75e-05 | 17 | 14 | 2 | CID000101562 | |
| Drug | trimethylphosphine | 1.51e-04 | 30 | 14 | 2 | CID000068983 | |
| Drug | Dexamethasone acetate [1177-87-3]; Down 200; 9.2uM; PC3; HT_HG-U133A | 2.10e-04 | 195 | 14 | 3 | 5797_DN | |
| Drug | Tetrahydroalstonine [6474-90-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.10e-04 | 195 | 14 | 3 | 2748_DN | |
| Drug | Butylparaben [94-26-8]; Down 200; 20.6uM; HL60; HT_HG-U133A | 2.13e-04 | 196 | 14 | 3 | 3069_DN | |
| Drug | Antimycin A [1397-94-0]; Up 200; 7.2uM; PC3; HT_HG-U133A | 2.13e-04 | 196 | 14 | 3 | 2098_UP | |
| Drug | LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.16e-04 | 197 | 14 | 3 | 6935_DN | |
| Drug | Thiocolchicoside [602-41-5]; Up 200; 7uM; HL60; HG-U133A | 2.16e-04 | 197 | 14 | 3 | 1726_UP | |
| Drug | antibiotic from Streptomyces | 2.98e-04 | 42 | 14 | 2 | CID000005153 | |
| Drug | acetic anhydride | 3.58e-04 | 46 | 14 | 2 | CID000007918 | |
| Drug | phorbol 12,13-diacetate | 3.90e-04 | 48 | 14 | 2 | CID000072293 | |
| Drug | quinoline | 6.29e-04 | 61 | 14 | 2 | CID000007047 | |
| Drug | beta-carboline | 6.93e-04 | 64 | 14 | 2 | CID000064961 | |
| Drug | Bmps | 8.05e-04 | 69 | 14 | 2 | CID004620597 | |
| Drug | 4 alpha-phorbol | 1.78e-03 | 103 | 14 | 2 | CID000028683 | |
| Disease | Intellectual Disability | 6.86e-04 | 447 | 12 | 3 | C3714756 | |
| Disease | mean arterial pressure | 9.44e-04 | 499 | 12 | 3 | EFO_0006340 | |
| Disease | bilirubin measurement | 1.34e-02 | 442 | 12 | 2 | EFO_0004570 | |
| Disease | Alzheimer disease | 1.60e-02 | 485 | 12 | 2 | MONDO_0004975 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DMAKSHRDIMSWLSK | 186 | P12645 | |
| SQFWIMEKTKAIMKH | 286 | Q8TAM1 | |
| SSSMKKDETHVKMES | 226 | O60812 | |
| SSSMKKDETHVKMES | 226 | B2RXH8 | |
| MIKETMDKKFGSSWH | 56 | O96015 | |
| KRKSSTMVKEGWMVH | 411 | O94806 | |
| LKIVKKMMDTHGSWM | 151 | Q6UWY5 | |
| LKSMMSSSIWESLSK | 3166 | Q0VDD8 | |
| TKKDTMEWHSQMHSV | 1016 | Q9P2F6 | |
| KSIDMSWDSVTMKHK | 156 | Q9UHX1 | |
| EDIKTMEMVKTKWDH | 1436 | Q8NF91 | |
| KITKMKVTMVAWDRH | 421 | Q8WWQ0 | |
| KWVEMTSHWEKTMSR | 66 | Q8IV04 | |
| MATNKTKSWKDKVAH | 526 | Q9UH65 |